National
National news in brief
Gay man leads in close vote for Gainesville mayor & more
Craig Lowe, who’s gay, appeared to narrowly beat his opponent Tuesday to become the next mayor of Gainesville, Fla. (Photo courtesy of Craig Lowe for Mayor)
Gay man leads in close vote for Gainesville mayor
GAINESVILLE, Fla. — The city of Gainesville, Fla., on Tuesday appeared to elect an openly gay man as mayor by 35 votes.
Craig Lowe, a 52-year-old gay city commissioner, beat out Don Marsh, a window-cleaning business owner, in an apparent victory in the city’s mayoral runoff election.
County law in the area requires a recount in cases where victories are achieved by a margin of less than 0.5 percent. If Lowe survives this recount, he’ll become the first openly gay mayor in northern Florida, and one of fewer than 30 openly LGBT mayors serving in the United States, according to the Gay & Lesbian Victory Fund.
In a statement provided by Equality Florida, Lowe gave particular thanks to the organization’s political action committee for its assistance in his election.
“I would like to thank Equality Florida Action PAC for their tremendous help in my race,” Lowe said. ”Not only did they endorse my candidacy early on, they also served as a watchdog against the lies about my campaign and put people on the ground to help get our message out to voters.”
According to Equality Florida, Lowe endured “homophobic rhetoric and smear tactics” in the weeks before his win. A local church displayed a “No Homo Mayor” billboard on their front lawn.
In addition to the state LGBT organization, Lowe received endorsements from the Victory Fund as well as other local organizations such as the Gainesville Professional Firefighters’ Association, the African American Coalition for Political Action and the Alligator Newspaper.
Senate passes resolution against anti-gay Uganda bill
WASHINGTON — The U.S. Senate on Tuesday approved by unanimous consent a resolution condemning a harshly anti-gay bill pending in the Ugandan parliament.
Sen. Russ Feingold (D-Wis.), chair of the Senate Foreign Relations subcommittee on African affairs, introduced the resolution in February. Sens. Tom Coburn (R-Okla.), Ben Cardin (D-Md.) and Susan Collins (R-Maine) were original co-sponsors.
Homosexual acts are already illegal in Uganda, but the African nation’s pending legislation would, among other things, institute the death penalty in some cases for LGBT people and require citizens to report LGBT people to the police.
In a statement, Feingold praised “so many political, religious and civic leaders in Uganda and around the world” for speaking out against the Uganda bill.
“Sadly, this legislation is just one example of actions taken around the world to restrict the rights of people just because of their gender or sexual orientation,” he said. “We need to speak out consistently against all such discrimination. The Senate’s passage of this resolution begins to move us in that direction, and I will continue working with my colleagues and the administration to continue to address this issue.”
In addition to condemning the Uganda bill, the Senate resolution calls for repeal of the criminalization of homosexuality in other countries and urges the State Department to closely monitor human rights abuses against LGBT people abroad.
In the House, another resolution condemning the Uganda legislation, introduced by Rep. Howard Berman (D-Calif.), is pending before the House Foreign Affairs Committee. The resolution has 58 co-sponsors.
HRC says Vatican official ‘diverting attention’ on abuses
WASHINGTON — The Human Rights Campaign this week accused a Vatican official of “diverting attention away from decades of Vatican cover-ups of pedophile behavior” when he blamed gays for the abuses.
Cardinal Tarcisio Bertone, the pope’s top aide, outraged gay advocacy groups, politicians and others with his remarks Monday in Chile.
“Many psychologists and psychiatrists have demonstrated that there is no relation between celibacy and pedophilia,” said the Italian cardinal, according to the Associated Press. “But many others have demonstrated, I have been told recently, that there is a relation between homosexuality and pedophilia. That is true. That is the problem.”
Harry Knox, an HRC director of religion issues, responded to Bertone on Wednesday.
“Cardinal Bertone’s statement makes clear that he is more interested in diverting attention away from decades of Vatican cover-ups of pedophile behavior than he is in living up to his pastoral role,” Knox said. “He should actually get to know gay people and read the voluminous opinions of medical and psychological experts that make clear pedophilia is not related to sexual orientation.”
Huckabee likens gay marriage to incest, polygamy
WASHINGTON — Mike Huckabee, a possible Republican presidential candidate in 2012, said the effort to allow same-sex couples to marry is comparable to legalizing incest, polygamy and drug use.
The Associated Press reported that Huckabee also told college journalists last week that gay couples should not be permitted to adopt. “Children are not puppies,” he said.
Huckabee visited The College of New Jersey in Ewing, N.J., April 7 to speak to the Student Government Association. He also was interviewed by a campus news magazine, The Perspective, which published an article April 9.
Huckabee told the interviewer that not every group’s interests deserve to be accommodated, if their lifestyle is outside of what he called “the ideal.”
“That would be like saying, well there are a lot of people who like to use drugs so let’s go ahead and accommodate those who want to use drugs. There are some people who believe in incest, so we should accommodate them. There are people who believe in polygamy, should we accommodate them?” he said, according to a transcript of the interview.
The 2008 presidential hopeful and former Arkansas governor also said that deciding which lifestyles should be accommodated and which ones should not creates a slippery slope.
“Why do you get to choose that two men are OK but one man and three women aren’t OK?” he asked.
Huckabee added that his goal isn’t to tell others how to live, but that the burden of proving that a gay marriage can be successful rests with the activists in favor of changing the law.
“I don’t have to prove that marriage is a man and a woman in a relationship for life,” he said. “They have to prove that two men can have an equally definable relationship called marriage, and somehow that that can mean the same thing.”
Since the magazine published the interview, Huckabee’s remarks have attracted considerable attention online.
In a statement Tuesday, Huckabee said that while he believes what people do in their private lives is their business, “I do not believe we should change the traditional definition of marriage.” He also said he thought the college magazine was sensationalizing his “well-known and hardly unusual views of same-sex marriage.”
Calif. gay marriage ban repeal falls short
SAN FRANCISCO — Gay rights activists say they have failed to qualify a measure that would repeal California’s same-sex marriage ban for the November ballot.
The Associated Press reported that Restore Equality 2010 chair Sean Bohac said the volunteer-run group fell short of gathering the nearly 695,000 signatures needed to put the initiative before voters. Monday was the deadline for submitting the signatures to the secretary of state’s office.
Bohac said Restore Equality’s failed effort was undermined by the decision of more established gay rights groups not to participate in the campaign. He noted that same-sex marriage supporters now are turning their attention to trying to repeal Proposition 8 in 2012.
A lawsuit to overturn Prop 8 also is pending before a federal trial judge.
Lance Bass, others sponsor gay-friendly prom
TUPELO, Miss. — Green Day, former ‘N Sync member Lance Bass and celebrity chef Cat Cora are among those helping to pay for a gay-friendly prom in Mississippi next month, the Associated Press reported.
Organizers say the event is open to everyone but geared toward gay students. The American Humanist Association also will contribute $20,000 for the May 8 event in Tupelo.
The annual prom is organized by the Mississippi Safe Schools Coalition. This year’s event has drawn attention because of the case of Constance McMillen, a high school senior who challenged her school district’s rule banning same-sex dates at proms.
Coalition spokesperson Matthew Sheffield said plans for the event haven’t been completed. But he noted that Bass, who is gay, is among the celebrities expected to attend.
Federal Government
Holiday week brings setbacks for Trump-Vance trans agenda
Federal courts begin to deliver end-of-year responses to lawsuits involving federal transgender healthcare policy.
While many Americans took the week of Christmas to rest and relax, LGBTQ politics in the U.S. continued to shift. This week’s short recap of federal updates highlights two major blows to the Trump-Vance administration’s efforts to restrict gender-affirming care for minors.
19 states sue RFK Jr. to end gender-affirming care ban
New York Attorney General Letitia James announced on Tuesday that the NYAG’s office, along with 18 other states (and the District of Columbia), filed a lawsuit to stop U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. from restricting gender-affirming care for minors.
In the press release, Attorney General James stressed that the push by the Trump-Vance administration’s crusade against the transgender community — specifically transgender youth — is a “clear overreach by the federal government” and relies on conservative and medically unvalidated practices to “punish providers who adhere to well-established, evidence-based care” that support gender-affirming care.
“At the core of this so-called declaration are real people: young people who need care, parents trying to support their children, and doctors who are simply following the best medical evidence available,” said Attorney General James. “Secretary Kennedy cannot unilaterally change medical standards by posting a document online, and no one should lose access to medically necessary health care because their federal government tried to interfere in decisions that belong in doctors’ offices. My office will always stand up for New Yorkers’ health, dignity, and right to make medical decisions free from intimidation.”
The lawsuit is a direct response to HHS’ Dec. 18 announcement that it will pursue regulatory changes that would make gender-affirming health care for transgender children more difficult, if not impossible, to access. It would also restrict federal funding for any hospital that does not comply with the directive. KFF, an independent source for health policy research, polling, and journalism, found that in 2023 federal funding covered nearly 45% of total spending on hospital care in the U.S.
The HHS directive stems directly from President Donald Trump’s Jan. 28 Executive Order, Protecting Children From Chemical and Surgical Mutilation, which formally establishes U.S. opposition to gender-affirming care and pledges to end federal funding for such treatments.
The American Medical Association, the nation’s largest and most influential physician organization, has repeatedly opposed measures like the one pushed by President Trump’s administration that restrict access to trans health care.
“The AMA supports public and private health insurance coverage for treatment of gender dysphoria and opposes the denial of health insurance based on sexual orientation or gender identity,” a statement on the AMA’s website reads. “Improving access to gender-affirming care is an important means of improving health outcomes for the transgender population.”
The lawsuit also names Oregon, Washington, California, Colorado, Connecticut, Delaware, the District of Columbia, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Mexico, Pennsylvania, Rhode Island, Vermont, and Wisconsin as having joined New York in the push against restricting gender-affirming care.
At the HHS news conference last Thursday, Jim O’Neill, deputy secretary of the department, asserted, “Men are men. Men can never become women. Women are women. Women can never become men.”
DOJ stopped from gaining health care records of trans youth
U.S. District Judge Cathy Bissoon blocked an attempt by the Department of Justice (DOJ) to gain “personally identifiable information about those minor transgender patients” from the University of Pittsburgh Medical Center (UPMC), saying the DOJ’s efforts “fly in the face of the Supreme Court.”
Journalist Chris Geidner originally reported the news on Dec. 25, highlighting that the Western District of Pennsylvania judge’s decision is a major blow to the Trump-Vance administration’s agenda to curtail transgender rights.
“[T]his Court joins the others in finding that the government’s demand for deeply private and personal patient information carries more than a whiff of ill intent,” Bissoon wrote in her ruling. “This is apparent from its rhetoric.”
Bissoon cited the DOJ’s “incendiary characterization” of trans youth care on the DOJ website as proof, which calls the practice politically motivated rather than medically sound and seeks to “…mutilate children in the service of a warped ideology.” This is despite the fact that a majority of gender-affirming care has nothing to do with surgery.
In United States v. Skrmetti, the Supreme Court ruled along party lines that states — namely Tennessee — have the right to pass legislation that can prohibit certain medical treatments for transgender minors, saying the law is not subject to heightened scrutiny under the Equal Protection Clause of the Fourteenth Amendment because it does not involve suspect categories like race, national origin, alienage, and religion, which would require the government to show the law serves a compelling interest and is narrowly tailored, sending decision-making power back to the states.
“The government cannot pick and choose the aspects of Skrmetti to honor, and which to ignore,” Judge Bissoon added.
The government argued unsuccessfully that the parents of the children whose records would have been made available to the DOJ “lacked standing” because the subpoena was directed at UPMC and that they did not respond in a timely manner. Bissoon rejected the timeliness argument in particular as “disingenuous.”
Bissoon, who was nominated to the bench by then-President Obama, is at least the fourth judge to reject the DOJ’s attempted intrusion into the health care of trans youth according to Geidner.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
How to cope when a partner gives you the silent treatment
Out actor talks lead role in ‘Fiddler on the Roof’
This gay author sees dead people
Holiday week brings setbacks for Trump-Vance trans agenda
Your guide to D.C.’s queer New Year’s Eve parties
Your guide to D.C.’s queer New Year’s Eve parties
Holiday week brings setbacks for Trump-Vance trans agenda
Out actor talks lead role in ‘Fiddler on the Roof’
This gay author sees dead people
